Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$1.7M Sell
7,742
-150
-2% -$33.9K 1.55% 19
2023
Q2
$1.78M Sell
7,892
-95
-1% -$19K 1.55% 19
2023
Q1
$1.53M Sell
7,987
-1,190
-13% -$230K 1.36% 24
2022
Q4
$1.69M Hold
9,177
1.5% 23
2022
Q3
$1.53M Sell
9,177
-550
-6% -$112K 1.45% 23
2022
Q2
$2.35M Hold
9,727
1.86% 14
2022
Q1
$2.35M Hold
9,727
1.86% 14
2021
Q4
$2.37M Buy
+9,727
New +$2.22M 1.73% 17

Other funds holding STE

Kenfarb & Co's STE Position: Q3 2023 in Review

Kenfarb & Co reduced its Steris (STE) stake by 1.9% in Q3 2023, selling an estimated $33.9K and leaving 7,742 shares worth $1.7M. The position accounts for 1.55% of the portfolio, ranked #19.

Kenfarb & Co first reported a position in STE in Q4 2021 and has held it in 8 quarters since. The position peaked at $2.37M in Q4 2021. 682 funds tracked by Wall St. Rank hold STE as of Q3 2023.

  • Kenfarb & Co held 7,742 shares of Steris worth $1.7M as of Q3 2023.
  • Kenfarb & Co sold 150 Steris shares in Q3 2023, an estimated $33.9K.
  • Steris made up 1.55% of Kenfarb & Co's portfolio in Q3 2023, its #19 holding.
  • Kenfarb & Co first reported a position in Steris in Q4 2021 and has held it in 8 quarters since.
  • Kenfarb & Co's Steris position peaked at $2.37M in Q4 2021.
  • 682 funds tracked by Wall St. Rank held Steris as of Q3 2023.

Based on Kenfarb & Co's 13F filing for Q3 2023, filed 14 Nov 2023.